Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study by Ren, Zhenggang, Prof, Xu, Jianming, Prof, Bai, Yuxian, Prof, Xu, Aibing, Prof, Cang, Shundong, Prof, Du, Chengyou, Prof, Li, Qiu, Prof, Lu, Yinying, Prof, Chen, Yajin, Prof, Guo, Yabing, Prof, Chen, Zhendong, Prof, Liu, Baorui, Prof, Jia, Weidong, Prof, Wu, Jian, Prof, Wang, Junye, Prof, Shao, Guoliang, Prof, Zhang, Bixiang, Prof, Shan, Yunfeng, Prof, Meng, Zhiqiang, Prof, Wu, Jianbing, Prof, Gu, Shanzhi, Prof, Yang, Wei, Prof, Liu, Chao, Prof, Shi, Xuetao, Prof, Gao, Zhenyuan, Prof, Yin, Tao, Prof, Cui, Jiuwei, Prof, Huang, Ming, Prof, Xing, Baocai, Prof, Mao, Yilei, Prof, Teng, Gaojun, Prof, Qin, Yanru, Prof, Wang, Jinhai, Prof, Xia, Feng, Prof, Yin, Guowen, Prof, Yang, Yong, MD, Chen, Mingxia, MD, Wang, Yan, MD, Zhou, Hui, MD, Fan, Jia, Prof

Get full text

Associations of long-term nitrogen dioxide exposure with a wide spectrum of diseases: a prospective cohort study of 0·5 million Chinese adults by Xia, Xi, PhD, Meng, Xia, PhD, Liu, Cong, PhD, Guo, Yi, MPhil, Li, Xinyue, MPhil, Niu, Yue, PhD, Lam, Kin Bong Hubert, PhD, Wright, Neil, PhD, Kartsonaki, Christiana, DPhil, Chen, Yiping, DPhil, Yang, Ling, PhD, Du, Huaidong, PhD, Yu, Canqing, PhD, Sun, Dianjianyi, PhD, Lv, Jun, Prof, Chen, Junshi, Prof, Yang, Xiaoming, PhD, Gao, Ruqin, MPhil, Wu, Shaowei, Prof, Kan, Haidong, Prof, Chan, Ka Hung, DPhil, Li, Liming, Prof, Chen, Zhengming, Prof

Get full text